The proposed project aims to enhance Alzheimer’s biomarkers detection by developing an innovative business model through the Lab to Market (L2M) program. This four-month initiative, in collaboration with the Innovation + Impact Network of Canada (I-INC), focuses on leveraging the entrepreneurial and innovative skills of participants to accelerate the translation of research excellence into practical […]
Read More